The modulatory effect of aminothiols on the clastogenic activity of X-rays assayed by the in vivo mouse micronucleus test

Folia Biologica

Volumn 44, Issue 1-2, 1996, Pages 55-59

  Mazur, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

AET; mouse peripheral blood micronucleus test; WR 2721; X rays

Indexed keywords

AMIFOSTINE; AMINOETHYLISOTHIOURONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; RADIATION PROTECTION; X RAY;

AMIFOSTINE; ANIMALS; ANTIMUTAGENIC AGENTS; BETA-AMINOETHYL ISOTHIOUREA; MALE; MICE; MICRONUCLEUS TESTS; RADIATION-PROTECTIVE AGENTS; X-RAYS;

ANIMALIA;

EID: 0029798203     PISSN: 00155497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BACQ Z. N., GOUTIER R. 1967. Mechanisms of action of sulfur-containing radioprotectors. (In: Recovery and Repair Mechanisms in Radiobiology, Brookhaven Symposia in Biology) 20: 241-262.
2. BROWN P. E. 1967. Mechanism of action of aminothiol radioprotectors. Nature 214: 363-364.
3. FAHEY R. C. 1988. Protection of DNA by thiols. Pharmac. Ther. 39: 101-108.
4. FLOERSHEIM G. L., FLOERSHEIM P. 1986. Protection against ionising radiation and synergism with thiols by zinc aspartate. Brit. J. Radiol. 59: 597-602.
5. GHOSE A., SRINIVASAN M. N. 1980. Ineffectiveness of 2-mercaptopropionylglycine in increasing survival of mice after gamma irradiation either alone or in combination with 2-aminoethyl isothiouronium bromide hydrobromide. J. Radiat. Res. 21: 197-203.
6. GRAWE J., ZETTERBERG G., AMNEUS H. 1993. DNA content determination of micronucleated polychromatic erythrocytes induced by clastogens and spindle poisons in mouse bone marrow and peripheral blood. Mutagenesis 8: 249-255.
7. GREENSTOCK C. L. 1986. Radiation-induced aging and induction and promotion of biological damage. (In: Free Radicals, Aging, and Degenerative Diseases, Liss, New York): 197-219.
8. GREENSTOCK C. L. 1988. Radiation chemical consideration for the radioprotection of cellular targets. Pharmac. Ther. 39: 139-145.
9. GUDI R., XU J., THILAGAR A. 1992. Assessement of the in vivo aneuploidy/micronucleus assay in mouse bone marrow cells with 16 chemicals. Environ. Molec. Mutagen. 20: 106-116.
10. HANAKI A., HANAKI T., OYA K., ANDOU A., HINO T., AKABOSHI S. 1966. Reactivities of radiation-protective amminoalkylisothiuronium salts. I. Hydrogen ion liberation of 2-aminoethylisothiuronium and 3-aminopropylisothiuronium bromide hydrobromide. Chem. Pharm. Bull. 14: 108-113.
11. HEDDLE J. A. 1973. A rapid in vivo test for chromosomal damage. Mutation Res. 18: 187-190.
12. HEDDLE J. A., SALAMONE M. F. 1981. Chromosomal aberrations and bone marrow toxicity. Environ. Health Perspect. 39: 23-27.
13. HELD K. D. 1988. Models for thiol protection of DNA in cells. Pharmac. Ther. 39: 123-131.
14. JAGETIA G. C. 1990. Frequency of micronucleated cells in the mouse bone marrow after exposure to various doses of γ-irradiation. Mutation Res. 230: 45-48.
15. KRISHNA G., FIEDLER R., THEISS J. C. 1992. Simultaneous evaluation of clastogenicity, aneugenicity and toxicity in the mouse micronucleus assay using immunofluorescence. Mutation Res. 282: 159-167.
16. LIVESEY J. C., GRUBAUM Z., KROHN K. A. 1990. Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins. Biochem. Pharmacol.39: 1807-1812.
17. MAISIN J. R. 1975. Protective action, toxicity and mechanisms of action of sulphydryl radioprotectors. Studia Biophys. 53: 121-124.
18. MAVOURNIN K. H., BLAKEY D. H., CIMINO M. C., SALAMONE M. F., HEDDLE J. A. 1990. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutation Res. 239: 29-80.
19. 60Co gamma-irradiation of male mice. Acta Physiol. Hung. 77: 103-111.
20. MAZUR L. 1995. Frequency of micronuclei in mouse peripheral blood erythrocytes following WR-2721 application and X-irradiation. Folia biol. (Kraków) 43: 111-114.
21. MILAS L., HUNTER N., REID B. O., THAMES D. 1982. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Res. 42: 1838-1887.
22. MURRAY D., VAN ANKEREN S. C., MILAS L., MEYNR. E. 1988 Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival. Pharmac. Ther. 39: 151-153.
23. NORI D., KIM J. H., HILARIS B., CHU F. C. 1987. Radiosensitizers and protectors. (In: Radiation Therapy of Gynecologic Cancer. Liss, New York): 319-329.
24. PASCOE S., GAREHOUSE D. 1986. The use of a single haematoxylin and eosin staining procedure to demonstrate micronuclei within rodent bone marrow. Mutation Res. 164: 237-243.
25. ROMANTSEV E. F., FILIPPOVICH I. V., ZHULANOVA Z. I., BLOKHINA V. D., TREBENOK Z. A., KOLESNIKOV E. E., SHEREME-TYEVSKAY T. N., NIKOLSKY A. V., ZYMALEVA O. G. 1971. Effect of modifying factors on radiosensitive biochemical reactions. (In: Biochemical Indicators of Radiation Injury in Man. Atomic Energy Agency, Vienna): 105-112.
26. SAVAGE J. R. K. 1993. Update on target theory as applied to chromosome aberrations. Environ. Molec. Mutagen. 22: 198-207.
27. SCHMID W. 1975. The micronucleus test. Mutation Res. 31: 9-15.
28. SHAW L. M., GLOVER D., TURRISI A., BROWN D. Q., BONNER H. S., NORFLEET A. L., WEILER C., GLICK J. H., KLIGERMAN M. M. 1988. Pharmacokinetics of WR-2721. Pharmac. Ther. 39: 195-201.
29. SHAW L. M., BONNER H. S., BROWN D. Q. 1994. Metabolic pathways of WR-2721 (Ethyol, Amifostine) in the Balb/c mouse. Drug Metab. Dispos. 22: 895-902.
30. SHINODA M., SHIMIZU S., HINO T., AKABOSHI S. 1972. Pharmacological studies on chemical protectors against radiation. VII. Radiation protective activities of AET and its related compounds against X-irradiation. Yakugaku Zasshi 92:442-448.
31. WEISS J. F., KUMAR K. S., WALDEN T. L., NETA R., LANDAUER M. R., CLARK E. P. 1990. Advances in radioprotection through the use of combined agent regimens. Inter. J. Radiat. Biol. 57: 709-722.
32. 50/30 doses. Radiat. Res. 44: 621-628.